Charles B. Nemeroff

Article

Anxiolytics: Past, Present, and Future Agents

Original Research

Are Mood Disorders and Obesity Related? A Review for the Mental Health Professional

Original Research

Aripiprazole Augmentation of Antidepressants for the Treatment of Partially Responding and Nonresponding Patients With Major Depressive Disorder

Article

Use of Atypical Antipsychotics in Refractory Depression and Anxiety

Commentary

The Pervasive and Persistent Neurobiological and Clinical Aftermath of Child Abuse and Neglect

Article

Consensus Statement Update on Posttraumatic Stress Disorder From the International Consensus Group on Depression and Anxiety

Original Research

Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction

Article

Dosing the Antipsychotic Medication Olanzapine

Original Research

Efficacy and Tolerability of Controlled-Release and Immediate-Release Paroxetine in the Treatment of Depression

Article

An Ever-Increasing Pharmacopoeia for the Management of Patients With Bipolar Disorder.

Article

Improving Antidepressant Adherence

Original Research

Influence of Sex and Menopausal Status on Response, Remission, and Recurrence in Patients With Recurrent Major Depressive Disorder Treated With Venlafaxine Extended Release or Fluoxetine: Analysis of Data From the PREVENT Study

Article

Introduction. Developmental Neurobiology and Psychiatry: Challenges and Best Practices for Studies in Children and Adolescents

Article

Introduction: Fifty Years of Lithium Use in the Treatment of Bipolar Disorder

Article

Introduction/Lithium in the Treatment of Manic-Depressive Illness: An Update

Article

Introduction. Norepinephrine: Neurotransmitter for the Millennium

Article

Introduction. The Phenomenology and Treatment of Aggression Across Psychiatric Illnesses

Article

Introduction.

Article

Lithium Augmentation of Antidepressants in Treatment-Refractory Depression

Article

Neurobiological Consequences of Childhood Trauma

Article

The Neurobiology of Depression: Inroads to Treatment and New Drug Discovery

Original Research

The Pharmacokinetics of Sertraline Excretion Into Human Breast Milk: Determinants of Infant Serum Concentrations

Article

Prevalence and Management of Treatment-Resistant Depression

Original Research

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

Original Research

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

Article

Problems With Currently Available Antidepressants

Article

Quetiapine: Preclinical Studies, Pharmacokinetics, Drug Interactions, and Dosing

Letter to the Editor

Reply to Letter to the Editor "Continuing Dialogue on Incentive Bias"

Original Research

Safety of Available Agents Used to Treat Bipolar Disorder: Focus on Weight Gain

Article

The Treatment of Bipolar Depression

Original Research

Treatment of Posttraumatic Stress Disorder With Phenytoin: An Open-Label Pilot Study

Article

A Double-Blind, Multicenter, Parallel-Group Study of Paroxetine, Desipramine, or Placebo in Breast Cancer Patients (stages I, II, III, and IV) With Major Depression

Original Research

Anxiolytics: Past, Present, and Future Agents

Are Mood Disorders and Obesity Related? A Review for the Mental Health Professional

Aripiprazole Augmentation of Antidepressants for the Treatment of Partially Responding and Nonresponding Patients With Major Depressive Disorder

Use of Atypical Antipsychotics in Refractory Depression and Anxiety

The Pervasive and Persistent Neurobiological and Clinical Aftermath of Child Abuse and Neglect

Consensus Statement Update on Posttraumatic Stress Disorder From the International Consensus Group on Depression and Anxiety

Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction

Dosing the Antipsychotic Medication Olanzapine

Efficacy and Tolerability of Controlled-Release and Immediate-Release Paroxetine in the Treatment of Depression

An Ever-Increasing Pharmacopoeia for the Management of Patients With Bipolar Disorder.

Improving Antidepressant Adherence

Influence of Sex and Menopausal Status on Response, Remission, and Recurrence in Patients With Recurrent Major Depressive Disorder Treated With Venlafaxine Extended Release or Fluoxetine: Analysis of Data From the PREVENT Study

Introduction. Developmental Neurobiology and Psychiatry: Challenges and Best Practices for Studies in Children and Adolescents

Introduction: Fifty Years of Lithium Use in the Treatment of Bipolar Disorder

Introduction/Lithium in the Treatment of Manic-Depressive Illness: An Update

Introduction. Norepinephrine: Neurotransmitter for the Millennium

Introduction. The Phenomenology and Treatment of Aggression Across Psychiatric Illnesses

Introduction.

Lithium Augmentation of Antidepressants in Treatment-Refractory Depression

Neurobiological Consequences of Childhood Trauma

The Neurobiology of Depression: Inroads to Treatment and New Drug Discovery

The Pharmacokinetics of Sertraline Excretion Into Human Breast Milk: Determinants of Infant Serum Concentrations

Prevalence and Management of Treatment-Resistant Depression

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

Problems With Currently Available Antidepressants

Quetiapine: Preclinical Studies, Pharmacokinetics, Drug Interactions, and Dosing

Reply to Letter to the Editor "Continuing Dialogue on Incentive Bias"

Safety of Available Agents Used to Treat Bipolar Disorder: Focus on Weight Gain

The Treatment of Bipolar Depression

Treatment of Posttraumatic Stress Disorder With Phenytoin: An Open-Label Pilot Study

A Double-Blind, Multicenter, Parallel-Group Study of Paroxetine, Desipramine, or Placebo in Breast Cancer Patients (stages I, II, III, and IV) With Major Depression

Partial Response and Nonresponse to Antidepressant Therapy: Current Approaches and Treatment Options

ELSEWHERE:

FOLLOW US:

Charles B. Nemeroff

Anxiolytics: Past, Present, and Future Agents

Are Mood Disorders and Obesity Related? A Review for the Mental Health Professional

Aripiprazole Augmentation of Antidepressants for the Treatment of Partially Responding and Nonresponding Patients With Major Depressive Disorder

Use of Atypical Antipsychotics in Refractory Depression and Anxiety

The Pervasive and Persistent Neurobiological and Clinical Aftermath of Child Abuse and Neglect

Consensus Statement Update on Posttraumatic Stress Disorder From the International Consensus Group on Depression and Anxiety

Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction

Dosing the Antipsychotic Medication Olanzapine

Efficacy and Tolerability of Controlled-Release and Immediate-Release Paroxetine in the Treatment of Depression

An Ever-Increasing Pharmacopoeia for the Management of Patients With Bipolar Disorder.

Improving Antidepressant Adherence

Influence of Sex and Menopausal Status on Response, Remission, and Recurrence in Patients With Recurrent Major Depressive Disorder Treated With Venlafaxine Extended Release or Fluoxetine: Analysis of Data From the PREVENT Study

Introduction. Developmental Neurobiology and Psychiatry: Challenges and Best Practices for Studies in Children and Adolescents

Introduction: Fifty Years of Lithium Use in the Treatment of Bipolar Disorder

Introduction/Lithium in the Treatment of Manic-Depressive Illness: An Update

Introduction. Norepinephrine: Neurotransmitter for the Millennium

Introduction. The Phenomenology and Treatment of Aggression Across Psychiatric Illnesses

Introduction.

Lithium Augmentation of Antidepressants in Treatment-Refractory Depression

Neurobiological Consequences of Childhood Trauma

The Neurobiology of Depression: Inroads to Treatment and New Drug Discovery

The Pharmacokinetics of Sertraline Excretion Into Human Breast Milk: Determinants of Infant Serum Concentrations

Prevalence and Management of Treatment-Resistant Depression

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

Problems With Currently Available Antidepressants

Quetiapine: Preclinical Studies, Pharmacokinetics, Drug Interactions, and Dosing

Reply to Letter to the Editor "Continuing Dialogue on Incentive Bias"

Safety of Available Agents Used to Treat Bipolar Disorder: Focus on Weight Gain

The Treatment of Bipolar Depression

Treatment of Posttraumatic Stress Disorder With Phenytoin: An Open-Label Pilot Study

A Double-Blind, Multicenter, Parallel-Group Study of Paroxetine, Desipramine, or Placebo in Breast Cancer Patients (stages I, II, III, and IV) With Major Depression

Partial Response and Nonresponse to Antidepressant Therapy: Current Approaches and Treatment Options

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles